Poster presentation at NIH “Strategies for an HIV Cure” meeting in Bethesda, Maryland US
Bionor Pharma ASA has been selected to present a poster entitled “Approaching HIV Functional Cure Applying Vacc-4x, a peptide-based HIV Therapeutic Vaccine: Clinical Development Methodological Considerations” at the National Institute […]
Poster presentation at the 18th Institute of Human Virology Annual Conference
Preliminary data from a Bionor research project supported by the Research Council of Norway GLOBVAC program will be presented as a poster today at the 18th Annual International Meeting of […]
Bionor provides an update on scientific collaborations
(Oslo, Norway, 13 June 2016) Bionor Pharma ASA (Bionor) (OSE:BIONOR), today provides an update on scientific collaborations in relation to the company’s HIV immunotherapy pipeline. On 31 May 2016, the […]